Robbins Farley’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22K | Hold |
909
| – | – | 0.01% | 99 |
|
|
2025
Q1 | $23K | Hold |
909
| – | – | 0.01% | 92 |
|
|
2024
Q4 | $24.1K | Buy |
909
+188
| +26% | +$4.99K | 0.01% | 92 |
|
|
2024
Q3 | $20.9K | Sell |
721
-293
| -29% | -$8.48K | 0.01% | 94 |
|
|
2024
Q2 | $28.4K | Sell |
1,014
-149
| -13% | -$4.17K | 0.02% | 89 |
|
|
2024
Q1 | $32.3K | Hold |
1,163
| – | – | 0.02% | 84 |
|
|
2023
Q4 | $33.5K | Hold |
1,163
| – | – | 0.02% | 79 |
|
|
2023
Q3 | $38.6K | Sell |
1,163
-374
| -24% | -$12.4K | 0.03% | 82 |
|
|
2023
Q2 | $56.4K | Buy |
1,537
+500
| +48% | +$18.3K | 0.04% | 71 |
|
|
2023
Q1 | $42.3K | Sell |
1,037
-46
| -4% | -$1.88K | 0.03% | 75 |
|
|
2022
Q4 | $55.5K | Sell |
1,083
-18,502
| -94% | -$948K | 0.04% | 65 |
|
|
2022
Q3 | $857K | Sell |
19,585
-52,808
| -73% | -$2.31M | 0.7% | 48 |
|
|
2022
Q2 | $3.8M | Sell |
72,393
-156
| -0.2% | -$8.18K | 3.96% | 3 |
|
|
2022
Q1 | $3.76M | Buy |
+72,549
| New | +$3.76M | 2.83% | 10 |
|
|
2021
Q4 | – | Sell |
-98,108
| Closed | -$4.22M | – | 202 |
|
|
2021
Q3 | $4.22M | Buy |
98,108
+5,900
| +6% | +$254K | 3.11% | 5 |
|
|
2021
Q2 | $3.61M | Buy |
+92,208
| New | +$3.61M | 4.07% | 9 |
|
|
2021
Q1 | – | Sell |
-122,645
| Closed | -$4.52M | – | 198 |
|
|
2020
Q4 | $4.52M | Buy |
+122,645
| New | +$4.52M | 4.45% | 3 |
|